English   español  

Browsing by Author Nistal, Manuel

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
RightsPreviewIssue DateTitleAuthor(s)Type
openAccess1471-2407-6-254.pdf.jpg25-Oct-2006Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastomaLázcoz, Paula; Muñoz, Jorge; Nistal, Manuel; Pestaña, Ángel; Encío, Ignacio; Castresana, Javier S.artículo
openAccessijo_29_2_335_PDF.pdf.jpgAug-2006Generation and characterization of monoclonal antibodies against choline kinase α and their potential use as diagnostic tools in cancerGallego Ortega, David CSIC ORCID; Ramírez de Molina, Ana; Gutierrez, Ruth; Ramos, Maria Angeles CSIC; Sarmentero Estrada, Jacinto; Cejas, Paloma; Nistal, Manuel; González Barón, Manuel; Lacal, Juan Carlos CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2013IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancerCortés-Sempere, María; Castro Carpeño, Javier de; Nistal, Manuel; Belda-Iniesta, Cristobal; Perona Abellón, Rosario CSIC ORCID; Ibáñez de Cáceres, Inmaculada CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpgJun-2010IGFBP-3 promoter methylation activates the PI3K/Akt intracellular signaling pathway in CDDP resistant cell linesCortés-Canteli, Marta CSIC ORCID; Miguel, María Paz de; Belda-Iniesta, Cristobal; Nistal, Manuel; Perona Abellón, Rosario CSIC ORCID; Ibáñez de Cáceres, Inmaculada CSIC ORCIDpóster de congreso
closedAccessaccesoRestringido.pdf.jpg2008Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomasPeinado, Héctor; Moreno-Bueno, Gema CSIC ORCID; Pérez-Gómez, Eduardo CSIC ORCID CVN; Santos, Vanesa CSIC; Mendiola, Marta; Nistal, Manuel; Quintanilla, Miguel CSIC ORCID; Portillo, Francisco CSIC; Cano, Amparo CSICartículo
closedAccessaccesoRestringido.pdf.jpg2009MKP1 repression is required for the chemosensitizing effects of NF-κB and PI3K inhibitors to cisplatin in non-small cell lung cancerCortés-Sempere, María; Rodriguez-Fanjul, V. CSIC ORCID; Belda-Iniesta, Cristobal; Cejas, Paloma; Machado-Pinilla, R. CSIC; Manguan-García, Cristina CSIC; Sánchez-Pérez, Isabel; Nistal, Manuel; Moratilla, Carmen CSIC; Castro Carpeño, Javier de; González Barón, Manuel; Albanell, Joan; Perona Abellón, Rosario CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2006MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancerChattopadhyay, S.; Machado-Pinilla, R. CSIC; Manguan-García, Cristina CSIC; Belda-Iniesta, Cristobal; Moratilla, Carmen CSIC; Fresno Vara, Juan Ángel CSIC; Castro Carpeño, Javier de; Casado, Enrique; Nistal, Manuel; González Barón, Manuel; Perona Abellón, Rosario CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2007Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sitesCéspedes, María Virtudes; Espina, Carolina; García-Cabezas, Miguel Angel CSIC ORCID; Gómez del Pulgar, Teresa; Nistal, Manuel; Lacal, Juan Carlos CSIC ORCID; Mangues, Ramónartículo
closedAccessaccesoRestringido.pdf.jpg2009The BRAFV600E oncogene induces transforming growth factor β secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancerRiesco-Eizaguirre, Garcilaso; Rodríguez, Irene; Vieja, Antonio de la CSIC ORCID CVN; Costamagna, Eugenia; Carrasco, Nancy; Nistal, Manuel; Santisteban, Pilar CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2006The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membraneRiesco-Eizaguirre, Garcilaso; Gutiérrez-Martínez, P.; García-Cabezas, Miguel Angel CSIC ORCID; Nistal, Manuel; Santisteban, Pilar CSIC ORCIDartículo